In 2011 our Muscle Group expanded to 26 laboratories
that are part of The Ohio State University and Nationwide Children’s
Hospital. These laboratories
span over a wide range of Schools, Colleges, Departments, and Divisions that
highlight the diversity of muscle research being performed within our respective
institutions.
Sudha Agarwal, Ph.D. |
Mechanosignaling in skeletal muscle |
Martha Belury, Ph.D., R.D. |
Adipokine signaling and metabolism in skeletal muscle |
Tom Best, M.D., Ph.D. |
Muscle strain injury, inflammation, adaptation to exercise |
Christine Beattie, Ph.D. |
Motorneuron diseases, motor axon outgrowth and development |
Brandon Biesiadecki, Ph.D. |
Myofilament regulation of muscle contraction |
Arthur Burghes, Ph.D. |
Motorneuron diseases and muscular atrophy |
Dawn Chandler, Ph.D. |
Alternative splicing in cancer and neurodegenerative disease |
Jonathan Davis, Ph.D. |
Skeletal and cardiac muscle contraction and relaxation |
Kevin M. Flanigan, M.D. |
Mechanisms and therapies of muscular dystrophies |
Denis Guttridge, Ph.D. |
NF-kB signaling in myogenesis and skeletal muscle disorders |
Scott Harper, Ph.D. |
Molecular mechanisms of muscular dystrophies, RNAi therapies |
Timothy E. Hewett, Ph.D. |
Biomechanics, injury prevention, and neuromuscular performance |
Peter Houghton, Ph.D. |
Pathogenesis of childhood cancers including Rhabdomyosarcoma |
Paul Janssen, Ph.D. |
Myocardial relaxation and molecular mechanisms of heart failure |
Stephen Kolb, M.D., Ph.D. |
Mechanisms of motor neuron diseases |
Brian Kaspar, Ph.D. |
Translational studies in neuromuscular disorders |
Donna McCarthy, Ph.D., R.N. |
Mechanisms of tumor-induced muscle wasting |
Paul Martin, Ph.D. |
Muscular dystrophy, neuromuscular disorders, glycobiology |
Jerry Mendell, M.D. |
Gene therapy, clinical trials in muscular dystrophy |
Federica Montanaro, Ph.D. |
Muscular dystrophy, muscle regeneration, cell-based therapy |
Christopher Pierson, M.D., Ph.D. |
Pathogenesis of X-linked myotubular myopathy |
Jill Rafael-Fortney, Ph.D. |
NMJ structure, muscular dystrophy and cardiomyopathy |
Jack Rall, Ph.D. |
Calcium control of skeletal and cardiac muscle contraction |
Peter Reiser, Ph.D. |
Sarcomeric proteins and contractile properties of muscle |
Zarife Sahenk, M.D. |
Molecular mechanisms of hereditary peripheral neuropathies |
Mark Ziolo, Ph.D. |
Nitric oxide modulation of excitation-contraction coupling |